Gene · 6470
Papers1,819
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,819
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs as Regulators of Cancer Cell Energy Metabolism. | J Pers Med | 2022 | 36013278 | PubTator, text mining | PubMed |
| Folic Acid and the Prevention of Birth Defects: 30 Years of Opportunity and Controversies. | Annu Rev Nutr | 2022 | 35995050 | PubTator, text mining | PubMed |
| Targeting HOTAIRM1 ameliorates glioblastoma by disrupting mitochondrial oxidative phosphorylation and serine metabolism. | iScience | 2022 | 35992092 | PubTator, text mining | PubMed |
| Untargeted Metabolomics and Transcriptomics Reveal the Mechanism of Metabolite Differences in Spring Tender Shoots of Tea Plants of Different Ages. | Foods | 2022 | 35954069 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT. | EMBO Mol Med | 2022 | 35920001 | PubTator, text mining | PubMed |
| Genetically modified metallothionein/cellulose composite material as an efficient and environmentally friendly biosorbent for Cd2+ removal. | Int J Biol Macromol | 2022 | 35902013 | PubTator, text mining | PubMed |
| Non-Targeted Metabolomics Approach Revealed Significant Changes in Metabolic Pathways in Patients with Chronic Traumatic Encephalopathy. | Biomedicines | 2022 | 35885023 | PubTator, text mining | PubMed |
| An Interplay between Epigenetics and Translation in Oocyte Maturation and Embryo Development: Assisted Reproduction Perspective. | Biomedicines | 2022 | 35884994 | PubTator, text mining | PubMed |
| Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics. | Biomolecules | 2022 | 35883465 | PubTator, text mining | PubMed |
| Metabolite Damage and Damage Control in a Minimal Genome. | mBio | 2022 | 35862786 | PubTator, text mining | PubMed |
| Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. | J Hematol Oncol | 2022 | 35851420 | PubTator, text mining | PubMed |
| Targeting mitochondrial metabolism for precision medicine in cancer. | Cell Death Differ | 2022 | 35831624 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| eNAMPT Neutralization Preserves Lung Fluid Balance and Reduces Acute Renal Injury in Porcine Sepsis/VILI-Induced Inflammatory Lung Injury. | Front Physiol | 2022 | 35812318 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| miR-218-5p/RUNX2 Axis Positively Regulates Proliferation and Is Associated with Poor Prognosis in Cervical Cancer. | Int J Mol Sci | 2022 | 35805994 | PubTator, text mining | PubMed |
| SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT. | Genomics | 2022 | 35798250 | PubTator, text mining | PubMed |
| De Novo Glycine Synthesis Is Reduced in Adults With Morbid Obesity and Increases Following Bariatric Surgery. | Front Endocrinol (Lausanne) | 2022 | 35757406 | PubTator, text mining | PubMed |
| Deciphering Metabolic Adaptability of Leukemic Stem Cells. | Front Oncol | 2022 | 35756656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6470/papers?page=18